Fifty patients with mild-to-moderate ulcerative
colitis that had failed to respond sufficiently to mesalamine were randomly assigned to receive, in double-blind fashion, 3 g per day of curcumin (in 2 divided doses per day before meals) or placebo for 1 month, while continuing mesalamine.
19, 2015 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited [TSE: 4502],("Takeda") today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative
colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology (ACG) Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21, and during the United European Gastroenterology Week (UEGW) annual meeting, which takes place in Barcelona, Spain from October 24-28.
Current Trial will Investigate APD334 for Ulcerative
Ferring Pharmaceuticals announced today the European launch of CORTIMENTAMMXA (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative
colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.
colitis is chronic recurring ulceration of the rectum and colon.
SeeNews) - Feb 17, 2014 - Belgian biotechnology firmA GalapagosA (EBR:GLPG) said Monday it had completed patient recruitment for Phase II trials with GLPG0974 in ulcerative
1-3) Two recognized entities, ulcerative
colitis (UC) and Crohn disease (CD), constitute chronic inflammatory bowel diseases (IBDs).
Adalimumab, a subcutaneously administered tumor necrosis factor blocker, has been approved for treating adults with moderately to severely active ulcerative
colitis who have not had an adequate response with conventional treatments, the FDA announced last month.
Crohn's disease, ulcerative
colitis, and pouchitis after ileal pouch anal anastomosis in ulcerative
colitis patients are often refractory to standard therapy.
Washington, Feb 7 (ANI): Researchers have linked 29 genome regions with ulcerative
colitis - a common form of inflammatory bowel disease (IBD).
For Patients With Active, Mild to Moderate Ulcerative
The drug is an antiinflammatory agent approved for the treatment of mild-to-moderate ulcerative